Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)
Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The MONET BRIDGE study is designed to assess the use of cangrelor as a platelet-inhibiting
bridge for patients who discontinue DAPT before cardiac and non cardiac surgery within 12
months from coronary stent implantation. It seeks to determine if initiation of a prolonged
cangrelor infusion maintains effective platelet inhibition after discontinuation of P2Y12 and
whether a cangrelor infusion before cardiac and non cardiac procedures is safe.